ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,514 Cr | ₹1,520 Cr | ₹1,641 Cr | ₹1,831 Cr | ₹1,533 Cr |
What is the latest Total Current Liabilities ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,514 Cr |
| Mar2024 | ₹1,520 Cr |
| Mar2023 | ₹1,641 Cr |
| Mar2022 | ₹1,831 Cr |
| Mar2021 | ₹1,533 Cr |
How is Total Current Liabilities of ALEMBIC PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,514 Cr | 65.38 | |
| Mar2024 | ₹1,520 Cr | -7.35 | |
| Mar2023 | ₹1,641 Cr | -10.37 | |
| Mar2022 | ₹1,831 Cr | 19.39 | |
| Mar2021 | ₹1,533 Cr | - | |
Compare Total Current Liabilities of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹14,450.1 Cr | -0.3% | -4.3% | -24.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | 0.6% | -2.8% | 6.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,570.0 Cr | 0.4% | 0.1% | 0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,670.0 Cr | 3.4% | 4.3% | 42% | Stock Analytics | |
| CIPLA | ₹111,725.0 Cr | -1.3% | 7% | -7.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,424.0 Cr | -0.2% | 0.4% | -1.4% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | -0.3% |
-4.3% |
-24.3% |
| SENSEX | -0.7% |
-2.9% |
-8.9% |
You may also like the below Video Courses